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Introduction 
The boundary between biology and chemistry has eroded 
in recent years. The integration of these disciplines has 
brought an increasingly molecular perspective to bear on 
biological systems. Once thought of as intractable, biomol- 
ecules are now manipulated as compounds with defined 
structures and chemical reactivities. The logical extension 
of this view is to approach cells as complex machines whose 
architecture and metabolic pathways can be understood 
and manipulated at the molecular level. This vision has led 
to the development of the rapidly expanding field of cellu- 
lar engineering which, even at this early stage, has already 
produced innovations such as cell-based biocatalysts [l-3] 
and biosensors [4,5]. 
The processes governed by cell-surface molecules are fun- 
damental to many biological phenomena and have attracted 
attention to the cell surface as an appealing target for engi- 
neering. Methods for controlling the display of membrane- 
associated epitopes offer a multitude of opportunities for 
studying cellular adhesion, signal transduction and cell-cell 
recognition events. In addition, cell-surface molecules are 
uniquely accessible to the outside world and have been rec- 
ognized as convenient hosts for epitope libraries [6]. Here 
we summarize current approaches to cell-surface engineer- 
ing and discuss present challenges and future directions. 
Due to the limited space available and the rapid expansion 
of this area of research, we are unable to cite all of the perti- 
nent literature. We have chosen a few representative exam- 
ples, and in some cases review articles, to highlight the 
salient topics in cell-surface engineering. 
The mechanisms used to landscape cell surfaces can be 
broadly divided into three main categories: first, recruit- 
ment of the cell’s genetic machinery for epitope expres- 
sion; second, external delivery of novel epitopes to cell 
surfaces; and third, metabolic incorporation of epitopes into 
cell-surface molecules. The most prevalent cell-surface 
biopolymers are proteins and oligosaccharides, the latter 
typically being presented in the context of membrane-asso- 
ciated glycoproteins or glycolipids. As a result, these mol- 
ecules have been the targets of most of the cell-surface 
engineering efforts to date (Figure 1). 
Genetic approaches to protein epitope 
expression 
Transfection of cells with genes encoding novel protein 
epitopes is a straightforward strategy for engineering cell 
surfaces. The challenge in this area is to identify a mecha- 
nism for directing the protein of interest to the outer 
surface of the membrane (or cell wall in the case of yeast, 
Gram-positive bacteria and plant cells). In eukaryotic cells, 
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The landscape of the cell surface and opportunities for molecular 
engineering. (a) Membrane-associated protein. Novel protein or 
peptide epitopes (shown in green) can be expressed on cell surfaces 
as fusion proteins with a membrane-spanning domain (or cell-wall- 
anchored domain in the case of yeast, plant cells and Gram-positive 
bacteria) from another protein (shown in blue). (b) Glycosyl- 
phosphatidylinositol (GPI)-anchored protein. Proteins can be directed 
to the cell surface in eukaryotic cells as fusions with a consensus 
sequence for the attachment of a GPI anchor (shown in blue). 
GPI-anchored proteins can also be coated onto cell surfaces 
exogenously by passive adsorption from the extracellular milieu. 
(c) Pore-forming protein. Proteins from the extracellular environment 
can insert into the plasma membrane to form organized functional 
assemblies, such as gated pores that regulate membrane permeability. 
(d) Membrane-associated glycoprotein. New oligosaccharide epitopes 
(shown in pink) can be engineered by the expression of glycosyl- 
transferases, by exogenous enzymatic remodeling, or by the metabolic 
incorporation of unnatural monosaccharides. (e) Glycolipid. Oligo- 
saccharide epitopes (shown in pink) on glycolipids can be altered 
similarly to glycoproteins. New oligosaccharide epitopes can also be 
delivered to cell surfaces by passive adsorption of hydrophobic 
glycosides from the extracellular milieu. 
this transformation can be accomplished by appending the 
gene encoding the protein epitope of interest to that 
encoding an appropriate leader sequence and membrane- 
spanning domain, often borrowed from another cell- 
surface-associated molecule. For example, Rieder et al. [7] 
used this technique to express a fusion protein composed 
of a virus-binding antibody and the membrane-associated 
molecule ICAM- on the surface of eukaryotic cells. This 
epitope acted as a novel cell-surface receptor, conferring 
upon its host cell the ability to be selectively infected by 
foot-and-mouth disease virus. 
Proteins can also be directed to the plasma membrane by 
the addition of a glycosylphosphatidylinositol (GPI) anchor 
attachment consensus sequence at the carboxyl terminus 
(such proteins can also be released from the plasma mem- 
brane by co-expression with a GPI-specific phospholipase) 
[8-l 11. Compared to fusion with a transmembrane domain 
from a different protein, the addition of a GPI anchor 
sequence is a minor modification and is less likely to cause 
gross structural alterations. This approach has been suc- 
cessful in the identification of Rubella virus glycoproteins 
responsible for cell-surface binding, for example [12]. 
Th e practice of cell-surface protein engineering has 
recently been expanded beyond basic research applications 
and into the biotechnology arena. With the advent of 
high-throughput screening methods using fluorescence 
activated cell sorters (FACS), the display of epitope 
libraries on the surface of microbes and yeast has become 
an attractive strategy for identifying high-affinity ligands, 
complementing similar strategies based on phage display 
[13]. Several protein fusion-based strategies for cell- 
surface display have been pursued. In Gram-negative 
bacteria such as Eschericha co/i, peptides of less than 60 
amino acids in length have been incorporated into the 
cell-surface-exposed loops of a variety of outer mem- 
brane proteins (Omps) (Figure Za) [14-161. Peptide epi- 
topes have also been localized to the cell surface by their 
incorporation into the structural proteins of pili and fla- 
gella [17-191. Unfortunately, the introduction of larger 
polypeptides and proteins disrupts the structure and 
localization of these delivery vehicles, restricting the 
utility of this approach. The development of a chimeric 
vector composed of the outer membrane localization 
signal from the major lipoprotein of E. coli (Lpp) fused to 
a segment of the outer membrane protein OmpA 
(Lpp-OmpA) has led to the successful display of pro- 
teins of up to 54 kD in size (Figure Zb) [20,21]. Enzymes 
such as p-lactamase and libraries of antibody fragments 
have been presented on bacterial outer membranes using 
this technology. 
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Expression of novel peptide and protein epitopes on outer membrane 
proteins (Omps) in Gram-negative bacteria. (a) The expression of short 
peptides (~60 amino acids) can be accomplished by insertion into 
surface-exposed loops. (b) Larger proteins can be presented in the 
context of a fusion protein with an Lpp-OmpA hybrid (adapted from [6]). 
In Gram-positive bacteria, proteins can be targeted to the 
surface of the organism as fusions with cell-wall-associated 
molecules [22,23]. The cell-wall-associated domain of 
protein A from Staphylococcus aweus has been used as a 
vehicle for the presentation of an BO-amino-acid malaria- 
derived peptide antigen on the surface of Staphylococcus 
carnoms [ZZ]. Mice immunized with a Staphytylococms xyLos21s 
variant expressing human respiratory syncytial virus anti- 
gens on cell-wall-associated molecules produced a specific 
antibody, suggesting that it may be possible to use these 
bacteria in live vaccines [23]. 
Cell-surface engineering in yeast has been accomplished 
using fusion vectors with cell-wall-associated proteins such 
as the mating adhesion protein a-agglutinin or hsp150 
delta-carrier protein, the latter also leading to secretion 
[3,13,‘24-261. Schreuder etal [24] were the first to demon- 
strate this approach by targeting the enzyme P-galactosidase 
to yeast cell walls. The enzyme had increased proteolytic 
stability compared to the free enzyme, an advantage for 
cell-based biocatalysts. Recently, Tanaka and coworkers 
[26] have taken this technology one step further by engi- 
neering yeast cell surfaces to add a catalytic activity that 
confers a selective advantage. They delivered the enzyme 
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glucoamylase from R/i&opz~s oryzae onto the cell surface in 
the context of an a-agglutinin fusion protein, enabling the 
yeast to use starch as a carbon source and to grow on 
previously unusable media. 
Genetic approaches to oligosaccharide 
epitope expression 
Oligosaccharides are not under direct genetic control, but 
are the products of the expression of several genes in 
concert. The biosynthesis of oligosaccharides often follows 
a particular order of assembly which is dictated by the 
specificities of glycosyltransferases and their compartmen- 
talization along the secretory pathway. Consequently, engi- 
neering the expression of novel epitopes through genetic 
manipulations is not a straightforward affair. Nonetheless, 
several groups have gained insight into the biological roles 
of specific carbohydrate structures by the engineered 
expression or deletion of glycosyltransferases within the 
cell, leading to the presence or absence of the carbohydrate 
structure on the cell surface [27,28]. The power of this 
approach has been dramatically demonstrated by Lowe 
et al. [29], who discovered that transfection of fucosyltrans- 
ferase-deficient COS-1 cells with the cDNA for an al-+3 
fucosyltransferase conferred E-selectin binding activity. 
This observation suggested early on that fucose would be 
an important component of the selectin ligands, which has 
since been shown to be the case. Glycosyltransferase 
expression has also been used to modulate the metastatic 
activity of tumor cells. The enzyme N-acetylglucosaminyl- 
transferase V (GnT-V) is responsible for extending a 
mannose residue on N-linked oligosaccharides with a 
pl-+bGlcNAc branch, a cell-surface modification that cor- 
relates with high metastatic potential. N-Acetylglucos- 
aminyltransferase III (GnT-III) attaches a bisecting p1+4 
GlcNAc residue to the same mannose residue, thereby 
precluding GnT-V activity. Taniguchi et al. [30] over- 
expressed GnT-III in a metastatic cell line, and found that 
this suppressed metastasis, presumably by preventing the 
expression of the pl+bGlcNAc branch. 
External delivery of protein epitopes to cell 
surfaces 
Although genetic approaches have obvious advantages, 
many cells, such as primary cultures or those grown in 
viva, cannot be readily transfected. Moreover, the range of 
epitopes that can be expressed genetically is limited to a 
large extent by the natural biopolymer subunits and the 
specificities of the biosynthetic enzymes. These restric- 
tions have prompted the development of exogenous 
methods for cell-surface engineering. 
One of the mildest methods for introducing proteins onto 
cell surfaces is the passive adsorption of GPI-anchored 
proteins from the extracellular milieu [B]. Using this tech- 
nique, the amount of protein displayed on the surface can 
be readily controlled, and multiple GPI-anchored proteins 
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can be presented concurrently or in series on the same cell 
surface. Although cells engineered in this manner cannot 
replicate their remodeled state, their service in the func- 
tional analysis of cell-surface proteins is well documented. 
One of the first proteins studied by this method was decay 
accelerating factor (DAF), a component of normal human 
erythrocyte membranes that is deficient in patients suffer- 
ing from paroxysmal nocturnal hemoglobinuria (PNH) 
[31]. Its function as a suppressor of complement-mediated 
lysis was elucidated when it was discovered that incorpora- 
tion of DAF into erythrocytes from PNH patients pro- 
tected them from destruction. More recently, ‘artificial’ 
antigen-presenting cells have been generated by delivering 
GPI-anchored class I MHC-antigenic peptide complexes 
to cell surfaces [32,33]. 
Proteins that form suitable hydrophobic assemblies can 
insert directly into the plasma membrane without the aid 
of a GPI anchor. For example, Russo eta/. 1341 engineered 
a metal-binding variant of Staphylococcus aureus a-toxin 
which inserted into membranes and formed Zn2+-gateable 
ZOA pores in living cells. The transport of small molecules 
across the plasma membrane of these engineered cells was 
controlled by the reversible addition of a metal chelator, 
offering an approach to the selective permeabilization of 
cell membranes. 
External delivery of oligosaccharide epitopes to 
cell surfaces 
As discussed above, the control of oligosaccharide expres- 
sion by genetic methods suffers from a number of limita- 
tions. Several genes must be simultaneously expressed to 
obtain a complex oligosaccharide epitope, which may then 
be only a minor component of a heterogeneous mixture of 
glycoforms present on the cell surface. In contrast, the 
delivery of exogenous oligosaccharides to cell surfaces 
would allow control over the expression level and unifor- 
mity of the target epitope. A classical method for the mild 
attachment of carbohydrate moieties to cell surfaces is the 
passive adsorption of hydrophobic glycosides from the 
extracellular milieu, analogous to GPI-anchored protein 
adsorption [35-371. This method has been used to investi- 
gate the binding of bacterial lipopolysaccharide (LPS) to 
macrophage LPS-binding proteins [38,39] and to elucidate 
the role of the ganglioside GM1 as a ligand for a bacterial 
toxin [40]. 
The context in which carbohydrate epitopes are expressed 
(e.g., extended from the plasma membrane on glycopro- 
teins, or presented in clusters) may be an important factor 
in determining recognition on the cell surface. Thus, it 
would be best to introduce novel oligosaccharide epitopes 
in a manner that mimics their native environment. Ideally, 
these epitopes would be appended to existing glycocon- 
jugates. Remodeling of cell-surface glycoconjugates has 
been achieved with the use of glycosyltransferases and 
their sugar nucleotide substrates. Some of the most excit- 
ing work in this area has been motivated by the observa- 
tion that certain glycosyltransferases are permissive for 
unnatural substrates, enabling the enzymatic attachment 
of unnatural sugars onto cell surfaces and the expansion of 
the cell-surface carbohydrate repertoire. 
Sialyltransferases and fucosyltransferases appear to be par- 
ticularly relaxed with respect to substrate specificity, and 
both have been exploited for the introduction of unnatural 
carbohydrate epitopes onto cells. Brossmer and coworkers 
[41] decorated cells with 9-azido and 9-amino sialic acid 
analogs by first removing natural sialic acids enzymatically, 
and then reinstalling the unnatural analogs with a sialyl- 
transferase and the corresponding synthetic CMP-sialic acid 
derivatives. In a landmark study, Hindsgaul, Palcic and 
coworkers [42] demonstrated that a fucosyltransferase from 
human milk will transfer fucose analogs with C6 substi- 
tuents of enormous size and complexity onto cell-surface 
glycoconjugates. In principle, a complex epitope of any 
type could be delivered to cells in one enzymatic step. As a 
demonstration, these researchers synthesized a derivative of 
GDP-fucose carrying a blood group B trisaccharide and 
enzymatically transferred the complex structure onto cells 
[42,43] (Figure 3). Erythrocytes of blood type 0 were deco- 
rated with the blood group B trisaccharide in this way and 
displayed the B phenotype in a standard blood-typing assay. 
The power of this strategy is further highlighted in a 
recent study of the relative E-selectin and L-selectin 
binding affinities of synthetic oligosaccharides [44]. The 
oligosaccharides were displayed on Chinese hamster ovary 
(CHO) cells using the fucosyl transfer approach, and were 
found to have different relative binding activities from 
similar oligosaccharides in solution. This observation sug- 
gests that the context in which ligands are presented 
can affect the outcome of receptor-binding studies, and 
underscores the importance of cell-surface engineering 
technology for studying cell-surface receptor interactions. 
Metabolic delivery of novel epitopes to the 
cell surface 
It is now possible to create new cell-surface epitopes via 
metabolic incorporation of unnatural precursors into 
plasma membrane components. Oligosaccharides are par- 
ticularly amenable to this type of metabolic engineering 
since the enzymes and transport proteins in certain 
biosynthetic pathways are tolerant of unnatural substrates 
[45]. Cells will take up monosaccharide analogs from the 
extracellular environment and process them into cell- 
surface glycoconjugates. In contrast, the pathways for 
protein biosynthesis are more restrictive and only the most 
conservatively modified amino acids are accepted [46-SO]. 
Promiscuity in the sialic acid biosynthetic pathway has 
been studied in some detail, leading to new insights into 
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Figure 3 
Enzymatic transfer of a complex trisaccharide 
epitope onto cell-surface glycoconjugates [42]. 
Lewis a-(1 -+3/4) 
Fucosyltransferase 
the biological functions of cell-surface glycoconjugates. 
Sialic acid residues, which are biosynthesized from 
N-acetylmannosamine (ManNAc), terminate a large frac- 
tion of mammalian glycoconjugates and serve as ligands 
for a number of viral and bacterial receptors. Several in 
vitro studies have hinted at the permissive nature of the 
enzymes in this pathway, especially with regard to the 
N-acyl substituent on N-acetylmannosamine. Reutter and 
coworkers [51,52] used this system to introduce unnatural 
N-propanoyl, N-butanoyl and N-pentanoyl sialic acids onto 
cells by feeding them the corresponding unnatural man- 
nosamine precursors (Figure 4a). The engineered cells 
showed altered ability to be infected with polyoma virus, 
which uses sialic acid as a ligand for binding prior to infec- 
tion [53]. These researchers also found that the presence 
of unnatural cell-surface sialic acids represses contact inhi- 
bition in cultured fibroblasts, suggesting a role for sialic 
acid in this critical event [.54]. 
In our own research group, rather than focusing on unnat- 
ural sugars as altered carbohydrate epitopes for the study 
of biological function, we have used oligosaccharide path- 
ways as vehicles to introduce novel chemical reactivity 
onto cell surfaces. For example, cells treated with N- 
levulinoylmannosamine (ManLev), an unnatural precursor 
to sialic acid that bears a ketone group, express the corres- 
ponding keto-sialic acid on cell-surface glycoconjugates 
(Figure 4b) [SS]. The ketones can be selectively ligated 
with hydrazide-, hydroxylamine- or thiosemicarbazide- 
conjugated molecules, allowing the cell surface to be 
chemically remodeled with a variety of epitopes. This 
approach combines aspects of both metabolic engineering 
and external chemical delivery and can, in principle, be 
extended to a number of different biosynthetic pathways 
and functional groups. 
Future directions 
The diverse array of strategies for cell-surface engineering 
represents the accumulation of increasingly powerful tools 
for manipulating cells at the genetic and biochemical 
level. Advances in these technologies will also produce 
new, multifaceted tactics for landscaping cell surfaces. 
The potential of these techniques is tremendous. Working 
together, chemists and biologists will be able to develop 
methods that combine genetic and metabolic engineering 
to introduce a range of unnatural epitopes onto cells 
without the restrictions imposed by nature’s biosynthetic 
machinery and metabolic building blocks. 
The boundaries of genetically controlled epitope expres- 
sion are constantly being expanded by revolutionary tech- 
nologies such as in viva unnatural amino acid mutagenesis 
[56]. The ability to evolve enzymes with new specificities 
also has far-reaching implications for metabolic engineer- 
ing [57]. For example, unnatural metabolic precursors and 
complementary biosynthetic enzymes could be combined 
to produce cells with rationally designed surfaces. These 
cells would produce progeny capable of creating similar 
unnatural surfaces. 
The opportunities afforded by cell-surface engineering are 
also rapidly expanding. The engineered adhesion of cells to 
synthetic matrices is of significant interest in biosensor and 
bioreactor design, and in the field of tissue engineering. At 
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Metabolic incorporation of unnatural mono- 
saccharides into cell-surface glycoconjugates. 
(a) Mannosamine derivatives with unnatural 
acyl groups (R) are taken up by cells, 
converted to the corresponding sialic acids, 
and presented on the cell surface in the 
context of glycoconjugates [53]. 
(b) Metabolic incorporation of a chemically 
reactive functional group into cell-surface 
sialic acids for chemical remodeling of cell 
surfaces. The ketone group, derived from 
N-levulinoylmannosamine (the sialic acid 
precursor), can be covalently ligated with 
hydrazide-functionalized epitopes [55]. 
present, research in these areas has focused on tailoring 
material surfaces to the adhesion preferences of the cell 
[58,59]. With improved cell-surface engineering technol- 
ogy, we may soon be able to tailor cell surfaces for preferred 
material substrates. Cells endowed with novel catalytic or 
receptor-binding activity may find use in tissue targeting 
and remodeling. And as the entire genome sequences of 
increasingly complex organisms continue to be defined, the 
idea of designing living cells with new properties comes 
into the realm of possibility. 
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